ABMD - Abiomed, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2020)Next Year (2021)
No. of Analysts8889
Avg. Estimate1.091.194.525.23
Low Estimate1.051.124.384.88
High Estimate1.121.294.726.03
Year Ago EPS0.971.095.14.52
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2020)Next Year (2021)
No. of Analysts8899
Avg. Estimate226.85M246.64M885.39M1.03B
Low Estimate221.6M242.44M876.67M1.01B
High Estimate233.54M251.1M890.1M1.05B
Year Ago SalesN/A207.08M769.43M885.39M
Sales Growth (year/est)N/A19.10%15.10%16.40%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.0.941.080.970.93
EPS Actual0.971.091.930.28
Difference0.030.010.96-0.65
Surprise %3.20%0.90%99.00%-69.90%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2020)Next Year (2021)
Current Estimate1.091.194.525.23
7 Days Ago1.091.194.525.23
30 Days Ago11.114.344.91
60 Days Ago11.114.354.94
90 Days Ago1.121.235.145.22
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2020)Next Year (2021)
Up Last 7 Days1111
Up Last 30 Days1111
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/A1N/A
Growth EstimatesABMDIndustrySectorS&P 500
Current Qtr.12.40%N/AN/A0.01
Next Qtr.9.20%N/AN/A0.06
Current Year-11.40%N/AN/A-0.02
Next Year15.70%N/AN/A0.14
Next 5 Years (per annum)24.00%N/AN/A0.07
Past 5 Years (per annum)60.37%N/AN/AN/A